Common diabetes medications, including sliding-scale insulin, sulfonylureas, and SGLT2 inhibitors, are considered potentially inappropriate for older adults due to the risk of hypoglycemia and other adverse effects, which may impact adherence.47 This evidence concerns the gene INS and Hypoglycemia.